Barclays PLC increased its stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 64.5% in the 3rd quarter, HoldingsChannel reports.The institutional investor owned 81,138 shares of ...
Results that may be inaccessible to you are currently showing.